FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

Psychedelics get a hearing at FDA

The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA.

FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace

By Puyaan Singh and Kamal Choudhury Sept 14 (Reuters) - The U.S. Food and Drug Administration will hold a public hearing on Monday to gather feedback on the potential therapeutic use of psychedelic drugs, the latest step in a months-long push by Presid...

Ensysce Biosciences Secures Podium at FDA Psychedelic Drug Hearing

Ensysce Biosciences sends Cy Biopharma's CMO to speak at a landmark FDA hearing on psychedelic drug therapies, targeting CRPS treatment.

Emyria selected for limited speaking spot at US FDA hearing

The ‘Considerations for Potential Future Therapeutic Use of Psychedelic Drugs’ hearing will be held at the FDA’s White Oak Campus ...